SCHEMBL29438567

SCHEMBL29438567

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@@H](O)COP(=O)(O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 10/20 0.64
ENPP2 Q13822 4/20 0.64
LPAR4 Q99677 3/20 0.64
LPAR5 Q9H1C0 3/20 0.64
LPAR2 Q9HBW0 3/20 0.64
LPAR3 Q9UBY5 3/20 0.64
LPAR6 P43657 2/20 0.64
CES2 O00748 1/20 0.64
TRPV1 Q8NER1 1/20 0.64
GPR55 Q9Y2T6 1/20 0.52
FAAH O00519 2/20 0.48
NR1I2 O75469 1/20 0.47
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS2 P35354 1/20 0.47
PDE4D Q08499 1/20 0.47
P2RY10 O00398 3/20 0.47
GPR174 Q9BXC1 3/20 0.47
GPR34 Q9UPC5 3/20 0.47
SELP P16109 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9905960 1.00 LPAR1 (0.64) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL9905935 0.92 LPAR1 (0.72) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL31442359 0.91 LPAR1 (0.78) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL6340011 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL13409099 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL29438562 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL9905951 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL6345706 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL6346455 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2
SCHEMBL29438566 0.90 LPAR1 (0.80) LPAR1ENPP2LPAR4LPAR5LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230305027-A1 METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES GENENTECH INC (US) 2023-09-28 US disclosed
EP-4189400-A2 METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES GENENTECH, INC. (US) 2023-06-07 EP disclosed
CN-116157688-A Methods for treating exacerbations of inflammatory respiratory diseases 基因泰克公司 2023-05-23 CN disclosed
WO-2022026922-A2 METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES GENENTECH, INC. (US) 2022-02-03 WO disclosed